Kerui Pharmaceutical-B (02171.HK) has granted 6,740,500 share options under the first public offering exercise.

Zhixun Finance APP news, Keji Pharmaceutical-B (02171.HK) announced that on September 18, 2025, the company granted 6.7405 million shares purchase rights to 348 purchase rights grantees in accordance with the terms of the first public offering after the purchase rights plan. However, the purchase rights grantees must accept before they can take effect.